Millennium Management’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-136,116
| Closed | -$1.31M | – | 4657 |
|
|
2024
Q4 | $1.31M | Sell |
136,116
-2,057,639
| -94% | -$19.8M | ﹤0.01% | 2743 |
|
|
2024
Q3 | $6.27M | Buy |
2,193,755
+1,550,785
| +241% | +$4.44M | ﹤0.01% | 1846 |
|
|
2024
Q2 | $1.88M | Sell |
642,970
-10,443
| -2% | -$30.5K | ﹤0.01% | 2518 |
|
|
2024
Q1 | $2.08M | Buy |
653,413
+60,835
| +10% | +$194K | ﹤0.01% | 2556 |
|
|
2023
Q4 | $1.99M | Sell |
592,578
-1,961,594
| -77% | -$6.59M | ﹤0.01% | 2461 |
|
|
2023
Q3 | $6.08M | Buy |
2,554,172
+1,409,821
| +123% | +$3.36M | ﹤0.01% | 1757 |
|
|
2023
Q2 | $2.01M | Buy |
1,144,351
+168,739
| +17% | +$297K | ﹤0.01% | 2522 |
|
|
2023
Q1 | $3.01M | Sell |
975,612
-671,285
| -41% | -$2.07M | ﹤0.01% | 2250 |
|
|
2022
Q4 | $8.73M | Buy |
1,646,897
+1,495,099
| +985% | +$7.92M | ﹤0.01% | 1694 |
|
|
2022
Q3 | $536K | Sell |
151,798
-860,717
| -85% | -$3.04M | ﹤0.01% | 3802 |
|
|
2022
Q2 | $2.61M | Buy |
1,012,515
+177,929
| +21% | +$459K | ﹤0.01% | 2664 |
|
|
2022
Q1 | $3.74M | Sell |
834,586
-61,928
| -7% | -$277K | ﹤0.01% | 2553 |
|
|
2021
Q4 | $6.11M | Sell |
896,514
-13,342
| -1% | -$90.9K | ﹤0.01% | 2058 |
|
|
2021
Q3 | $6.63M | Sell |
909,856
-136,267
| -13% | -$993K | ﹤0.01% | 1913 |
|
|
2021
Q2 | $10.5M | Sell |
1,046,123
-718,382
| -41% | -$7.2M | 0.01% | 1352 |
|
|
2021
Q1 | $16.9M | Buy |
1,764,505
+289,976
| +20% | +$2.77M | 0.01% | 919 |
|
|
2020
Q4 | $16.2M | Buy |
1,474,529
+1,008,070
| +216% | +$11.1M | 0.01% | 930 |
|
|
2020
Q3 | $4.14K | Buy |
+466,459
| New | +$4.14K | 0.01% | 1559 |
|